Fidelity Select Biotechnology Portfolio (FBIOX)
24.32
+0.05
(+0.21%)
USD |
May 19 2026
FBIOX Asset Allocations & Exposures
Asset Allocation
As of March 31, 2026.
| Type | % Net |
|---|---|
| Cash | -0.03% |
| Stock | 99.59% |
| Bond | 0.03% |
| Convertible | 0.00% |
| Preferred | 0.47% |
| Other | -0.06% |
Market Capitalization
As of March 31, 2026
| Large | 35.64% |
| Mid | 10.89% |
| Small | 53.47% |
Region Exposure
| Americas | 83.55% |
|---|---|
|
North America
|
83.55% |
| Canada | 0.46% |
| United States | 83.09% |
|
Latin America
|
0.00% |
As of March 31, 2026. Region breakdown data is
calculated by using the long position holdings of the portfolio.
| Greater Europe | 14.68% |
|---|---|
| United Kingdom | 3.48% |
|
Europe Developed
|
11.20% |
| Belgium | 2.21% |
| Denmark | 2.92% |
| France | 0.78% |
| Germany | 0.15% |
| Ireland | 1.09% |
| Netherlands | 2.71% |
| Sweden | 0.16% |
| Switzerland | 1.17% |
|
Europe Emerging
|
0.00% |
|
Africa And Middle East
|
0.00% |
| Greater Asia | 0.07% |
|---|---|
| Japan | 0.00% |
|
Australasia
|
0.00% |
|
Asia Developed
|
0.07% |
| Singapore | 0.07% |
|
Asia Emerging
|
0.00% |
| Unidentified Region | 1.70% |
|---|
Stock Sector Exposure
| Cyclical |
|
0.00% |
| Materials |
|
0.00% |
| Consumer Discretionary |
|
0.00% |
| Financials |
|
0.00% |
| Real Estate |
|
0.00% |
| Sensitive |
|
0.00% |
| Communication Services |
|
0.00% |
| Energy |
|
0.00% |
| Industrials |
|
0.00% |
| Information Technology |
|
0.00% |
| Defensive |
|
98.10% |
| Consumer Staples |
|
0.00% |
| Health Care |
|
98.10% |
| Utilities |
|
0.00% |
| Not Classified |
|
1.90% |
| Non Classified Equity |
|
1.85% |
| Not Classified - Non Equity |
|
0.05% |
As of March 31, 2026
Stock Style Exposure
| Large Cap Value | -- |
| Large Cap Core | -- |
| Large Cap Growth | -- |
| Mid Cap Value | -- |
| Mid Cap Core | -- |
| Mid Cap Growth | -- |
| Small Cap Value | -- |
| Small Cap Core | -- |
| Small Cap Growth | -- |